Comparison of two dosing regimens of PEG-interferon beta-1a in volunteers

Trial Profile

Comparison of two dosing regimens of PEG-interferon beta-1a in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2011

At a glance

  • Drugs Peginterferon beta-1a (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Biogen Idec
  • Most Recent Events

    • 16 Jun 2011 Results published in the Journal of Clinical Pharmacology, in combination with results from the phase Ia study (see 180253)
    • 12 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top